Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023 (CME VIDEOS)
$40.00
Video Course · Psychopharmacology · 2023
The psychopharmacology treatment advances 2023 course centers on treatment-resistant psychiatric patients and the interface between psychiatric, neurological, and medical illness, featuring legendary faculty including Charles Nemeroff, Stephen Stahl, and Daniel Weinberger.
-
12expert faculty
-
4panel discussions
-
2023edition
- Covers genomic sequencing to treatment-resistant depression and psychosis
- Explores psychedelics, ketamine, ECT, and TMS for resistant conditions
- Addresses women’s reproductive and child-adolescent psychopharmacology
- Includes four expert panel discussions on emerging treatment questions
Legendary Faculty on Treatment-Resistant Psychiatric Illness and Emerging Pharmacotherapies
psychopharmacology treatment advances 2023 centers on the treatment of difficult-to-treat psychiatric patients with emphasis on the interface between psychiatric, neurological, and medical illness. Legendary faculty including Daniel Weinberger, Charles Nemeroff, Stephen Stahl, and Alan Schatzberg review new antipsychotic medications, mood stabilizer applications, the neurobiologic mechanisms of depression, and the role of inflammation in treatment resistance — delivering psychopharmacology treatment advances grounded in the latest evidence base.
-
12expert faculty
-
4panel discussions
-
2023edition
Inside this resource
Schizophrenia, Bipolar, and Anxiety Disorders
Daniel Weinberger reviews genomic sequencing lessons from psychiatric patients, while sessions on schizophrenia address unsolved pharmacologic challenges and new antipsychotic augmentation strategies. Bipolar and anxiety disorder lectures explore emerging theories and current evidence-based treatments for these chronic conditions.
Depression, PTSD, and Sleep Disorders
Charles Nemeroff and Philip Harvey address the neurobiologic mechanisms of depression, treatment-resistant depression strategies, and the perils and possibilities of psychedelics and ketamine. PTSD and sleep disorder lectures cover emerging treatments alongside appropriate pharmacologic management of comorbid conditions.
ECT, TMS, and Substance Use Pharmacotherapy
Sessions on ECT and TMS provide guidance on when to utilize neuromodulation for treatment-resistant depression. Roger Weiss and colleagues address substance use pharmacotherapy, while Barbara Coffey and Ariadna Forray cover women’s reproductive psychopharmacology and gender-specific considerations.
Lifespan Psychopharmacology and Panel Discussions
Child, adolescent, and geriatric psychopharmacology sessions address age-specific prescribing challenges. Four panel discussions bring together multiple faculty members to debate unresolved treatment questions and emerging psychopharmacology treatment advances frontiers in real time.
Who this serves
- Psychiatrists managing treatment-resistant patients — seeking evidence-based augmentation and alternative strategies
- Psychopharmacology specialists — wanting to stay current on new medications, psychedelics, and neuromodulation
- Neurologists and internists — navigating the psychiatric-medical illness interface in complex patients
Faculty & syllabus
Faculty and topics 12 faculty
- Daniel Weinberger — genomic sequencing in psychiatric illness
- Martin Samuels — neurological and medical interface in psychiatry
- Charles Nemeroff — neurobiologic mechanisms of depression and inflammation
- Philip Harvey — treatment-resistant depression and emerging theories
- Ross Baldessarini — mood stabilizer applications and bipolar pharmacotherapy
- Stephen Stahl — new antipsychotic medications and augmentation strategies
- Sogol Javaheri — sleep disorders comorbid with psychiatric illness
- Alan Schatzberg — perils and possibilities of psychedelics and ketamine
- Roger Weiss — substance use pharmacotherapy and alcohol use disorders
- Barbara Coffey — child and adolescent psychopharmacology
- Ariadna Forray — women’s reproductive psychopharmacology
- Elizabeth Crocco — geriatric psychopharmacology and ECT applications
Before you buy
Does this cover psychedelic-assisted therapy?
Yes. A dedicated session explores the perils and possibilities of psychedelics and ketamine, examining current evidence, clinical protocols, and emerging applications in treatment-resistant depression and PTSD.
What makes this different from general psychopharmacology resources?
This course specifically targets the difficult-to-treat and treatment-resistant patient, with legendary faculty who shaped the evidence base rather than simply reviewing it. Four panel discussions add real-time expert debate on unresolved questions.
Are there panel discussions included?
Four panel discussions bring together multiple faculty members to address unresolved treatment questions, debate emerging evidence, and discuss the clinical application of psychopharmacology treatment advances across complex patient populations.
The chart
| Format | Video lectures |
|---|---|
| Faculty | 12 expert presenters |
| Year | 2023 |
| Publisher | Independent Medical Education |
| Department | Psychiatry |
| Delivery | Instant download after checkout · lifetime re-access |
Verified original fileInstant downloadEncrypted checkout
5 reviews for Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023 (CME VIDEOS)
Add a review
Related products
Pulmonary /Respiratory
29th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2025 (Videos + Slides)
Psychiatry
Priya N. –
Exceptional faculty but the sheer depth of content can be overwhelming for generalists. The women’s reproductive psychopharmacology and child-adolescent sections were particularly strong.
drtomh –
Charles Nemeroff and Stephen Stahl together in one program is worth the price alone. The treatment-resistant depression lectures changed how I approach augmentation strategies.
James L. –
Living up to its name, this course features legendary faculty across every major area of psychopharmacology. The four panel discussions added depth through real-time expert debate.
Lisa M. –
The psychedelics and ketamine session was timely and evidence-based without the hype. Daniel Weinberger’s genomic sequencing talk connected genetics to real clinical decision-making.
Mark R. –
World-class faculty delivering world-class content, but the video production quality varies across sessions. The ECT and TMS lectures and the substance use pharmacotherapy section were highlights.